Dr. Ray Lin, MD

Dr. Lin practices at Scripps Green Hospital in La Jolla, California, part of Scripps Health.

Dr. Lin's NPI, 1437110996, was assigned on March 31, 2006. Dr. Lin graduated from Loyola University Chicago Stritch School of Medicine in 1995. Dr. Lin holds California license A61565.

Dr. Lin's primary practice is Scripps Green Hospital, at 10666 North Torrey Pines Road, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 554-3600.

Dr. Lin's primary practice is Scripps Green Hospital in La Jolla, California, part of Scripps Health. Dr. Lin is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Lin to 3 more hospitals, 1 breast imaging center and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Lin is board certified in radiation oncology by the American Board of Radiology. Dr. Lin is licensed in California.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, lymphoma radiation, pancreatic cancer radiation and uterine cancer radiation among the conditions Dr. Lin treats.

CMS data shows 6,156 Medicare services from Dr. Lin across 33 procedure codes in 2024, for 550 Medicare patients. Medicare paid $665,023 for them.

CMS counts 550 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 254 patients. 73% of them have cancer, and 68% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 70, with 75% women.

In 2024, Dr. Lin wrote 70 Medicare Part D claims for 47 patients. 83% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $117 in total drug cost. In 2023, CMS named 45 claims across 3 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 6 papers to Dr. Lin, published from 2021 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Pancreatic Neoplasms. Dr. Lin's most frequent co-authors are Gregory P. Botta, MD, PhD, Darren Sigal, MD and Alexander Mark Agelidis.

Dmand AI links Dr. Lin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 119 general payments to Dr. Lin from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Brainlab, Inc. paid the most, $1,035.

Dmand AI lists 1 award for Dr. Lin.

Dr. Lin graduated from Loyola University Chicago Stritch School of Medicine in 1995.

Dr. Lin is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.